Anti-androgen enzalutamide enhances prostate cancer neuroendocrine (NE) differentiation via altering the infiltrated mast cells → androgen receptor (AR) → miRNA32 signals

Autor: Dang, Qiang a, b, 1, Li, Lei a, b, ∗, 1, Xie, Hongjun a, b, He, Dalin a, Chen, Jiaqi a, Song, Wenbing a, b, Chang, Luke S. a, Chang, Hong-Chiang b, Yeh, Shuyuan b, Chang, Chawnshang b, c, ∗
Zdroj: In Molecular Oncology August 2015 9(7):1241-1251
Databáze: ScienceDirect
Externí odkaz: